Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

BACKGROUND: The use of immune checkpoint inhibitors is increasing in cancer therapy today. It is critical that treatment teams become familiar with the organ systems potentially impacted by immune-related adverse events associated with these drugs. Here, we report adverse skeletal effects of immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Moseley, Kendall F., Naidoo, Jarushka, Bingham, Clifton O., Carducci, Michael A., Forde, Patrick M., Gibney, Geoffrey T., Lipson, Evan J., Shah, Ami A., Sharfman, William H., Cappelli, Laura C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180387/
https://www.ncbi.nlm.nih.gov/pubmed/30305172
http://dx.doi.org/10.1186/s40425-018-0417-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180387/
https://www.ncbi.nlm.nih.gov/pubmed/30305172
http://dx.doi.org/10.1186/s40425-018-0417-8

Ejemplares similares